Sponsored by Medicine Central
GLP-1 Receptor Agonists in Primary Care: Evidence, Prescribing & Patient Selection
A CPD-accredited webinar for UK primary care prescribers
About This Webinar
This free webinar provides a comprehensive update on GLP-1 receptor agonists, covering the latest clinical evidence, NICE guidance, and practical prescribing considerations for primary care. Our expert speaker will guide you through patient selection, monitoring, and managing side effects, with time for Q&A.
Learning Objectives
- Understand the latest NICE guidance on GLP-1 receptor agonists in type 2 diabetes
- Apply evidence-based prescribing principles for weight management in primary care
- Identify appropriate patient selection criteria for GLP-1 therapies
- Discuss monitoring requirements and managing common side effects
- Recognise when to refer patients to specialist services
Programme
Speaker
Dr Sarah Mitchell, MBBS MRCGP
Dr Mitchell is a GP partner with a specialist interest in metabolic medicine and diabetes. She has been involved in developing local prescribing guidelines for GLP-1 therapies across her ICB.
Sponsorship Disclosure
This webinar is organised and funded by Medicine Central. The content has been developed independently and is not influenced by any pharmaceutical company.
Registration
Free to attend · For UK healthcare professionals